{"id":540453,"date":"2021-09-21T08:33:32","date_gmt":"2021-09-21T12:33:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/"},"modified":"2021-09-21T08:33:32","modified_gmt":"2021-09-21T12:33:32","slug":"new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/","title":{"rendered":"New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS"},"content":{"rendered":"<h2>\nPeer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device Manufacturers<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>MALVERN, Pa., Sept.  21, 2021  (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders announced today that a peer-reviewed paper showed significantly lower seizure risk with NeuroStar<sup>\u00ae<\/sup> Advanced Therapy for Mental Health than with TMS treatments that claim deeper stimulation with H-Coil technology. The paper, titled \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=crC0nEsVNyeDOU02wAHerY2wyJiyAJfw5oi1V6oEL7UWa9YKzmX1rMxnuhUwKtzxO1qCskZzzcaBNfVyyBaiiOQp0LX5riiNoxz9jP0xh3SLmBPRQjXK8_pYCGnEmxXNG90Q0iXWAW9saDirkWrZImaUoXzt41NsQhY486xcMNuEuSssFLXaTYenZIujOs26CbJgryy7VZ21rFwS6RzziLEyuQxIKgaCJnInPadtLwFVDsu-koPKMAjS0ByHBEx8\" rel=\"nofollow noopener\" target=\"_blank\">Seizure risk with repetitive TMS: Survey results from over a half-million treatment sessions<\/a>\u201d published in <em>Brain Stimulation, <\/em>the premier journal for publication of original research in the field of neuromodulation, electronically surveyed all of the approximately 500 members of the Clinical TMS Society (CTMSS) about seizures in their practice.<\/p>\n<p>\u201cWhile the overall occurrence of seizures with all TMS treatments is low, this study showed that the real-world risk for seizure was 52 to 90 times higher with H-coil TMS treatment than with NeuroStar treatment,\u201d stated Cory Anderson, VP, Clinical Affairs &amp; Interim VP, R&amp;D, Neuronetics. \u201cFrom NeuroStar\u2019s Figure-8 coil design, to being backed by the largest clinical data set of any TMS treatment for depression, to our comprehensive training programs, Neuronetics always aspires to provide the safest and most efficacious treatment for our providers and their patients.\u201d<\/p>\n<p>One-hundred thirty-four surveys were returned and nine were excluded due to data inconsistencies, leaving a total of 125 surveys to evaluate which included 586,656 TMS treatment sessions. To distinguish seizures from non-seizures, a Board-certified neurologist and the Co-Chair of the CTMSS Standards Committee conducted remote interviews. The survey respondents included a wide range of clinical practices, and provided a way to estimate TMS seizure risk under real-world practice conditions. The resulting data provide the largest real-world sample size estimation of TMS seizure risk across device manufacturers. The authors hypothesized that the higher risk of seizure with the H-Coil design was due, in part, to the broader and less focused stimulation field which may stimulate unintended regions of the brain and lead to seizures.<\/p>\n<p>\u201cOne of the reasons I chose NeuroStar for my practice is the precision of the treatment,\u201d said Kenneth Pages, MD, TMS of South Tampa. \u201cPrecision is a critical component of TMS dosing and delivery. I trust NeuroStar\u2019s technology with Contact Sensing to give me peace of mind that my patients are receiving the treatment dose I\u2019ve prescribed, without treating areas of the brain that are unrelated to their depression.\u201d<\/p>\n<p>To learn more about NeuroStar<sup>\u00ae<\/sup> Advanced Therapy, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PWigGgSD_0xSb9QagpxctbJrKPIdt5p71K2k7F-AZy8gYu0aSOCBS6uMX8-mz9XZrZs_8MD4lUo7vrrksImfWA==\" rel=\"nofollow noopener\" target=\"_blank\">www.neurostar.com<\/a>.\u00a0\u00a0<\/p>\n<p>\n        <strong>About Neuronetics<\/strong><br \/>\n        <br \/>Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience and the largest TMS company in the industry, Neuronetics is redefining patient and physician expectations by designing and developing products that improve the quality of life for people suffering from neurohealth conditions. An FDA-cleared, non-drug, noninvasive treatment for people with depression, Neuronetics\u2019 NeuroStar<sup>\u00ae<\/sup> Advanced Therapy system is today\u2019s leading transcranial magnetic stimulation (TMS) treatment for major depressive disorder in adults with over four million treatments delivered. NeuroStar is widely researched and backed by the largest clinical data set of any TMS system for depression, including the world\u2019s largest depression Outcomes Registry. Neuronetics is committed to transforming lives by offering an exceptional treatment option that produces extraordinary results. For safety information and indications for use, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lEzQY7bdoiW2vewAw_rDfAxoqQ179-HNnJ4Bvg13men6BLcS5n23Qmkx1V0xmheKFoOGfx1VUh5qhGkKiim5SQ==\" rel=\"nofollow noopener\" target=\"_blank\">NeuroStar.com<\/a>.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>EvolveMKD<br \/>646.517.4220<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lEzQY7bdoiW2vewAw_rDfEQ3aB9gcHifffDgbuudUFRhrh0DE0ynGUevxqBtGsKXj320p-sJfWqg-Lrf9nKfdEqqEo8MGu-XtUAAAPW763Y=\" rel=\"nofollow noopener\" target=\"_blank\">NeuroStar@evolvemkd.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyODAxOCM0NDExMjE1IzIxMTA0NDA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MDM1ZTAwNTgtODFhYi00YWViLWFiN2MtNGE3MTllYmUzNzk5LTExMjIwMTE=\/tiny\/Neuronetics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Peer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device Manufacturers MALVERN, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders announced today that a peer-reviewed paper showed significantly lower seizure risk with NeuroStar\u00ae Advanced Therapy for Mental Health than with TMS treatments that claim deeper stimulation with H-Coil technology. The paper, titled \u201cSeizure risk with repetitive TMS: Survey results from over a half-million treatment sessions\u201d published in Brain Stimulation, the premier journal for publication of original research in the field of neuromodulation, electronically surveyed all of the approximately 500 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-540453","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Peer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device Manufacturers MALVERN, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders announced today that a peer-reviewed paper showed significantly lower seizure risk with NeuroStar\u00ae Advanced Therapy for Mental Health than with TMS treatments that claim deeper stimulation with H-Coil technology. The paper, titled \u201cSeizure risk with repetitive TMS: Survey results from over a half-million treatment sessions\u201d published in Brain Stimulation, the premier journal for publication of original research in the field of neuromodulation, electronically surveyed all of the approximately 500 &hellip; Continue reading &quot;New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-21T12:33:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyODAxOCM0NDExMjE1IzIxMTA0NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS\",\"datePublished\":\"2021-09-21T12:33:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/\"},\"wordCount\":579,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyODAxOCM0NDExMjE1IzIxMTA0NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/\",\"name\":\"New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyODAxOCM0NDExMjE1IzIxMTA0NDA=\",\"datePublished\":\"2021-09-21T12:33:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyODAxOCM0NDExMjE1IzIxMTA0NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyODAxOCM0NDExMjE1IzIxMTA0NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/","og_locale":"en_US","og_type":"article","og_title":"New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS - Market Newsdesk","og_description":"Peer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device Manufacturers MALVERN, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders announced today that a peer-reviewed paper showed significantly lower seizure risk with NeuroStar\u00ae Advanced Therapy for Mental Health than with TMS treatments that claim deeper stimulation with H-Coil technology. The paper, titled \u201cSeizure risk with repetitive TMS: Survey results from over a half-million treatment sessions\u201d published in Brain Stimulation, the premier journal for publication of original research in the field of neuromodulation, electronically surveyed all of the approximately 500 &hellip; Continue reading \"New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-21T12:33:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyODAxOCM0NDExMjE1IzIxMTA0NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS","datePublished":"2021-09-21T12:33:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/"},"wordCount":579,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyODAxOCM0NDExMjE1IzIxMTA0NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/","name":"New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyODAxOCM0NDExMjE1IzIxMTA0NDA=","datePublished":"2021-09-21T12:33:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyODAxOCM0NDExMjE1IzIxMTA0NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyODAxOCM0NDExMjE1IzIxMTA0NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-data-highlights-neurostar-advanced-therapy-for-mental-health-safety-over-h-coil-tms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"New Data Highlights NeuroStar\u00ae Advanced Therapy for Mental Health Safety Over H-Coil TMS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/540453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=540453"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/540453\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=540453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=540453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=540453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}